Investors
Shape the future of DMA® with us.
Our team has already made significant progress industrializing the prototype.
We are now developing the business and planning a multi-stage investment program and we are looking for financial partners willing to join such a mission with passion and valuable relations.
With your support, we can create a new, advanced screening process that will greatly enhance our ability to detect diseases at an early stage.
We believe that we have the potential to make a significant impact on the healthcare industry. We are confident that our innovative technologies and dedicated team will deliver exceptional results, and we invite you to be a part of this journey.
Together, we can make a positive impact on the lives of many and help advance the field of healthcare.
Social & Economic Implications. Significant social impacts and costs reduction for Public Healthcare Systems derives from: pre-screening limiting unnecessary expenses or invasive tests, early diagnosis, improving personalized care, which increases the efficiency of drug administration.
Clinical & Scientific Implications. Understanding of the individual metabolic profile help the discovery of diagnosis and treatments. Faster and more effective care of patients. Accurate personalization of the treatments. Opportunity for new research at pharmaceutical, biological, genomics, and clinical research.
Industrial Implications. Development and commercialization of new professional instruments and services in the life science sector. Speed-up the development of new drugs & nutritions reducing costs, risks, and time . New healthcare services available to the community. Commercial wellness tools (eg. wearables), and services can be derived from the professional versions. Health insurance companies might improve their services and reduce the costs.